Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Lifeward ( (LFWD) ) has provided an update.
On May 14, 2025, Lifeward Ltd. announced the appointment of Mark Grant as the new President and Chief Executive Officer, effective June 2, 2025. Grant, who brings over 30 years of experience in healthcare and medical technology, will initially serve as Co-CEO alongside outgoing CEO Larry Jasinski until June 30, 2025, before assuming the role solely. This leadership change is expected to drive Lifeward’s growth and innovation in the medical technology sector, leveraging Grant’s extensive experience in commercial leadership and strategic solutions. The transition is part of Lifeward’s strategic efforts to enhance its market position and continue delivering groundbreaking solutions for individuals with physical impairments.
The most recent analyst rating on (LFWD) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Lifeward stock, see the LFWD Stock Forecast page.
Spark’s Take on LFWD Stock
According to Spark, TipRanks’ AI Analyst, LFWD is a Neutral.
Lifeward’s stock score is influenced by strong revenue growth but substantial risks due to profitability challenges, negative cash flows, and unattractive valuation. Technical indicators and recent corporate events further underscore the cautious outlook, despite strategic initiatives. Key risks involve financial instability and operational inefficiencies.
To see Spark’s full report on LFWD stock, click here.
More about Lifeward
Lifeward Ltd. is a global leader in innovative medical technology, focusing on transforming the lives of individuals with physical limitations or disabilities. The company designs, develops, and commercializes solutions for physical rehabilitation and recovery, with a portfolio that includes products like the ReWalk Exoskeleton, AlterG Anti-Gravity system, MyoCycle FES System, and ReStore Exo-Suit. Founded in 2001, Lifeward operates in the United States, Israel, and Germany.
Average Trading Volume: 1,958,110
Technical Sentiment Signal: Sell
Current Market Cap: $14.31M
For detailed information about LFWD stock, go to TipRanks’ Stock Analysis page.